Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

DOI Full Paper Access

65

Citations

19

References

2022

Year

Hedy L. Kindler, Silvia Novello, Alessandra Bearz, Giovanni Luca Ceresoli, Joachim G.J.V. Aerts, James Spicer, Paul Taylor, Kristiaan Nackaerts, Alastair Greystoke, Ross Jennens,

The Lancet Oncology

Open-label Phase 2Pleural DiseaseOncologyRadiation OncologyRadiologyHealth Sciences

References

	Year	Citations

Page 1